Procalcitonin: From discovery to clinical use;La procalcitonine : de la découverte à l'utilisation clinique

Medecine Nucleaire

Volumn 32, Issue 3, 2008, Pages 132-137

  Chourrout, P ^a  

^a centre hospitalier d'Albi   (France)

Author keywords

Bacterial infections; Procalcitonin

Indexed keywords

PROCALCITONIN;

BACTERIAL INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HUMAN; INFLAMMATION; MENINGITIS; NEWBORN INFECTION; PROGNOSIS; SHORT SURVEY;

BACTERIA (MICROORGANISMS);

EID: 40849085010     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2007.01.008     Document Type: Short Survey

References (34)

1. Tubiana M., Milhaud G., Coutris G., Lacour J., Parmentier C., and Bok B. Medullary carcinoma and thyrocalcitonin. Br Med J 4 5623 (1968 Oct 12) 87-89
2. Jullienne A., Segond N., Calmettes C., Moukhtar M.S., and Milhaud G. Biosynthesis of human calcitonin: evidence for a prohormone. Biochem Biophys Res Commun 95 3 (1980 Aug 14) 932-937
3. Le Moullec J.M., Jullienne A., Chenais J., Lasmoles F., Guliana J.M., Milhaud G., et al. The complete sequence of human preprocalcitonin. FEBS Lett 167 1 (1984) 93-97
4. Bohuon C. A brief history of procalcitonin. Intensive Care Med 26 Suppl 2 (2000) S146-S147
5. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., and Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 (1993) 515-518
6. Becker K.L., Müller B., Nylén E.S., Cohen R., White J.C., and Snider Jr. R.H. Calcitonin gene family of peptides. Structure, molecular biology, and effects. Principles of Bone Biology. 2nd edition (2002), Academic Press pp. 629-39
7. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79 6 (1994) 1605-1608
8. Müller B., White J.C., Nylen E.S., Snider R.H., Becker K.L., and Habener J.F. Ubiquitous expression of the calcitonin-1. Gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 96 1 (2001) 396-404
9. Linscheid P., Seboek D., Nylen E.S., Langer I., Schlatter M., Becker K.L., et al. In vitro and in vivo calcitonin-I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144 12 (2003) 5578-5584
10. Nylen E.S., Whang K.T., Snider R.H., Steinwald P.M., White J.C., and Becker K.L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26 6 (1998) 1001-1006
11. Becker K.L., Nylén E.S., Snider R.H., Müller B., and White J.C. Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 9 6 (2003) 367-374
12. Guilloteau D., Perdrisot R., Calmettes C., Baulieu J.L., Lecomte P., Kaphan G., et al. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. J Clin Endocrinol Metab 71 4 (1990 Oct) 1064-1067
13. Cannarozzi D.B., Canale D.D., and Donabedian R.K. Hypercalcitoninemia in infancy. Clin Chim Acta 66 3 (1976 Feb 2) 3
14. Guibourdenche J., Bedu A., Petzold L., Marchand M., Mariani-Kurdjian P., Hurtaud-Roux M.F., et al. Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting. Ann Clin Biochem (2002) 130-135
15. Kouame D.B., Garrigue M.A., Lardy H., Machet M.C., Giraudeau B., and Robert M. La procalcitonine peut-elle aider au diagnostic des appendicites de l'enfant ?. Ann Chir 130 3 (2005) 169-174
16. Hausfater P., Garric S., Ben Ayed S., Rosenheim M., Bernard M., and Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34 (2002) 895-901
17. Gerlach M, Keh D, Ahlers 0, Kerner T, Spielmann S, Falke KJ, et al. Increased procalcitonin levels in polytrauma patients. Vienna Internat Congress. Anesthesiology and Intens Care Med 1997;335:28-31. (Abstract).
18. Meisner M., Tschaikowsky K., Hutzler A., Schick C., and Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24 (1998) 680-684
19. Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-α and endotoxin levels early after thermal injury. Burns 23 3 (1997) 218-224
20. Steinbach G., Bölke E., Grünert A., Orth K., and Störck M. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116 24 (2004) 849-853
21. Davis T.M.E., Assicot M., Bohuon C., St.John A., Li G.Q., and Anh T.K. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 88 6 (1994) 670-671
22. Chiwakata C.B., Manegold C., Bönicke L., Jülch C., and Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis 183 (2001) 1161-1164
23. Dornbusch H.J., Strenger V., Kerbl R., LacknerH, Schwinger W., Sovinz P., et al. Procalcitonin: a marker of invasive fungal infection?. Support Care Cancer 13 5 (2005) 343-346
24. Uzzan B., Cohen R., Nicolas P., Cucherat M., and Perret G.Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 17 (2006 May) 1-8
25. Castelli G.P., Pognani C., Cita M., Stuani A., Sgarbi L., Paladini R., et al. C-reactive protein, white blood cells and Sofa score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 72 1-2 (2006 Jan-Feb) 69-80
26. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huygens L., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 30 4 (2002) 757-762
27. Luyt C.E., Guerin V., Combes A., Trouillet J.L., Ben Ayed S., Bernard M., et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171 1 (2005) 48-53
28. Bohuon C., Assicot M., Raymond J., and Gendrel D. La procalcitonine, indicateur d'infection bactérienne dans les méningites de l'enfant. Bull Acad Natl Med 182 7 (1998) 1469-1475
29. Dubos F, Moulin F, Raymond J, Gendrel D, Bréart G, Chalumeau M. Distinction entre les méningites bactériennes et virales chez l'enfant : affinement d'une règle de décision clinique Arch Pediatr 2007;14(5):434-38.
30. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M.M., Huber P.R., Tamm M., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 9409 (2004) 600-607
31. Christ-Crain M., Stolz D., Bingisser R., Muller C., Miedinger D., Huber P.R., et al. Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med (2006 Apr 7) 1-43
32. Joram N., Boscher C., Denizot S., Loubersac V., Winer N., Roze J.C., et al. Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91 (2006) F65-F66
33. Leroy S., Adamsbaum C., Marc E., Moulin F., Raymond J., Gendrel D., et al. Procalcitonin as a predictor vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics (2005) 1631-2004
34. Robinson J.O., Calandra T., and Marchetti O. Utilité de la procalcitonine dans le diagnostic and le suivi des infections chez les patients neutropéniques fébriles. Rev Med Suisse Romande 1 13 (2005) 885-886